ArticleCureus2025
Rapid Progression of a Cavernous Sinus Dural Arteriovenous Fistula From Borden Type I to Type II: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cavernous sinus dural arteriovenous fistulas (CSdAVFs) are typically considered benign when classified as Borden type I, which is characterized by the absence of cortical venous reflux (CVR). These lesions are often managed conservatively with long-term follow-up imaging. Although progression to higher-risk types involving CVR can occur, it is generally gradual. A 74-year-old woman presented with recurrent diplopia due to a right abducens nerve palsy. Digital subtraction angiography revealed Borden type I CSdAVFs with venous drainage exclusively via the bilateral inferior petrosal sinuses, without evidence of CVR. Conservative management with follow-up MRI was initially planned. However, three months later, the patient developed new-onset pulsatile tinnitus and conjunctival injection. Follow-up imaging demonstrated newly developed CVR and altered venous drainage patterns, consistent with progression to Borden type II. Transvenous embolization resulted in the complete resolution of symptoms and a favorable clinical outcome (modified Rankin Scale score of 0). This case highlights the potential for rapid progression of CSdAVFs, even in lesions initially classified as Borden type I. Vigilant clinical monitoring and prompt re-imaging are essential when new symptoms emerge, even within a short interval following diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.